128 related articles for article (PubMed ID: 19349046)
1. Enzyme replacement therapy for Gaucher disease in twin pregnancy.
Malinová V; Poupetová H; Dvoráková L; Zeman J
Int J Gynaecol Obstet; 2009 Jul; 106(1):64-6. PubMed ID: 19349046
[No Abstract] [Full Text] [Related]
2. Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a Gaucher disease patient.
Aporta Rodriguez R; Escobar Vedia JL; Navarro Castro AM; Aguilar García G; Cabrera Torres A
Haematologica; 1998 Sep; 83(9):852-3. PubMed ID: 9825582
[TBL] [Abstract][Full Text] [Related]
3. Use of enzyme replacement therapy for Gaucher disease during pregnancy.
Elstein D; Granovsky-Grisaru S; Rabinowitz R; Kanai R; Abrahamov A; Zimran A
Am J Obstet Gynecol; 1997 Dec; 177(6):1509-12. PubMed ID: 9423759
[TBL] [Abstract][Full Text] [Related]
4. Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey.
Lau H; Belmatoug N; Deegan P; Goker-Alpan O; Schwartz IVD; Shankar SP; Panahloo Z; Zimran A
Blood Cells Mol Dis; 2018 Feb; 68():226-231. PubMed ID: 27839985
[TBL] [Abstract][Full Text] [Related]
5. Breastfeeding in Gaucher disease: is enzyme replacement therapy safe?
Dornelles AD; de Oliveira Netto CB; Vairo F; de Mari JF; Tirelli KM; Schwartz IV
Clin Ther; 2014 Jun; 36(6):990-1. PubMed ID: 24768190
[No Abstract] [Full Text] [Related]
6. [Gaucher disease and pregnancy].
Belmatoug N; Heraoui D
Presse Med; 2009 Dec; 38 Suppl 2():2S17-23. PubMed ID: 20304300
[No Abstract] [Full Text] [Related]
7. Successful pregnancy outcome in a patient with Gaucher's disease and antiphospholipid syndrome.
Sherer Y; Dulitzki M; Levy Y; Livneh A; Shoenfeld Y; Langevitz P
Ann Hematol; 2002 Mar; 81(3):161-3. PubMed ID: 11904743
[TBL] [Abstract][Full Text] [Related]
8. The management of pregnancy in Gaucher disease.
Granovsky-Grisaru S; Belmatoug N; vom Dahl S; Mengel E; Morris E; Zimran A
Eur J Obstet Gynecol Reprod Biol; 2011 May; 156(1):3-8. PubMed ID: 21269752
[TBL] [Abstract][Full Text] [Related]
9. Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease.
Elstein D; Hughes D; Goker-Alpan O; Stivel M; Baris HN; Cohen IJ; Granovsky-Grisaru S; Samueloff A; Mehta A; Zimran A
J Obstet Gynaecol Res; 2014 Apr; 40(4):968-75. PubMed ID: 24612151
[TBL] [Abstract][Full Text] [Related]
10. The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).
Zimran A; Morris E; Mengel E; Kaplan P; Belmatoug N; Hughes DA; Malinova V; Heitner R; Sobreira E; Mrsić M; Granovsky-Grisaru S; Amato D; vom Dahl S
Blood Cells Mol Dis; 2009; 43(3):264-88. PubMed ID: 19502088
[TBL] [Abstract][Full Text] [Related]
11. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
[No Abstract] [Full Text] [Related]
12. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
Cleary JE; Burke WM; Baxi LV
Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
[TBL] [Abstract][Full Text] [Related]
13. Evolving features in type 3 Gaucher disease on long-term enzyme replacement therapy.
Elstein D; Abrahamov A; Altarescu G; Zimran A
Blood Cells Mol Dis; 2013 Feb; 50(2):140. PubMed ID: 23085428
[No Abstract] [Full Text] [Related]
14. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
Sidransky E; Ginns EI; Westman JA; Ehmann WC
Am J Hematol; 1994 Nov; 47(3):247-9. PubMed ID: 7942798
[No Abstract] [Full Text] [Related]
15. Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy.
vom Dahl S; Niederau C; Häussinger D
N Engl J Med; 1998 May; 338(20):1471-2. PubMed ID: 9583981
[No Abstract] [Full Text] [Related]
16. Enzyme replacement in Gaucher disease.
Beutler E
PLoS Med; 2004 Nov; 1(2):e21. PubMed ID: 15578103
[TBL] [Abstract][Full Text] [Related]
17. Cardiac response to enzyme-replacement therapy in Gaucher's disease.
Spada M; Chiappa E; Ponzone A
N Engl J Med; 1998 Oct; 339(16):1165-6. PubMed ID: 9776652
[No Abstract] [Full Text] [Related]
18. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
[TBL] [Abstract][Full Text] [Related]
19. [Gaucher disease: enzyme replacement treatment initiated at pediatric age; 20-year experience].
Vitoria Miñana I; Dalmau Serra J
An Pediatr (Barc); 2016 Jun; 84(6):343-6. PubMed ID: 26724255
[No Abstract] [Full Text] [Related]
20. Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease.
Elstein D; Cohn GM; Wang N; Djordjevic M; Brutaru C; Zimran A
Blood Cells Mol Dis; 2011 Jan; 46(1):119-23. PubMed ID: 20727796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
